
1. BMJ. 2021 Oct 28;375:n2611. doi: 10.1136/bmj.n2611.

Safety and efficacy of antivirals against SARS-CoV-2.

Sidebottom DB(1)(2), Smith DD(1)(2), Gill D(3)(2).

Author information: 
(1)St George's, University of London, London, UK.
(2)St George's University Hospitals NHS Foundation Trust, London, UK.
(3)St George's, University of London, London, UK dipender.gill@nhs.net.

DOI: 10.1136/bmj.n2611 
PMID: 34711614  [Indexed for MEDLINE]

Conflict of interest statement: Competing interests: We have read and understood 
BMJ policy on declaration of interests and declare the following: DG is employed 
part time by Novo Nordisk and has received consultancy fees from Policy Wisdom,
unrelated to the submitted work.

